Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

UBQLN3 Activators

UBQLN3 Activators are a collection of chemicals that indirectly bolster the functional activity of UBQLN3 through multiple cellular signaling pathways and stress responses. Forskolin elevates cAMP, which activates PKA, potentially increasing phosphorylation events that modulate UBQLN3's activity in protein quality control. Ionomycin, by raising intracellular calcium levels, may influence UBQLN3's participation in calcium-dependent proteostasis. ALLN and MG132, by inhibiting calpain and the proteasome respectively, could lead to an accumulation of misfolded proteins, subsequently enhancing the role of UBQLN3 in protein triage decisions. Phorbol 12-myristate 13-acetate (PMA) activates PKC, possibly leading to phosphorylation of substrates that affect UBQLN3's function, while chloroquine and bafilomycin A1 disrupt lysosomal function, which may upregulate UBQLN3-mediated pathways as a compensatory mechanism.

Rapamycin and AICAR are known to induce autophagy; this might amplify UBQLN3's involvement in directing autophagic protein degradation. Retinoic acid could enhance UBQLN3 activity by modulating gene expression of proteins involved in UBQLN3-associated pathways. Tunicamycin and thapsigargin create ER stress by inhibiting glycosylation and disrupting calcium stores,respectively, potentially enhancing UBQLN3's response to misfolded proteins in the ER. The chemical influence of these activators demonstrates the multifaceted role of UBQLN3 in maintaining cellular proteostasis through various stress responses and regulatory mechanisms. Together, these compounds provide a diverse set of tools that can indirectly promote the functional activity of UBQLN3, ensuring the proper handling and turnover of proteins within the cell.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ionomycin, free acid

56092-81-0sc-263405
sc-263405A
1 mg
5 mg
$96.00
$264.00
2
(2)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially affecting calcium-dependent proteostasis mechanisms where UBQLN3 is involved.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132 inhibits the proteasome, which could lead to an accumulation of misfolded proteins, potentially increasing the demand for UBQLN3's role in protein degradation.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine inhibits lysosomal acidification, which may enhance UBQLN3's function by increasing the need for alternative degradation pathways that involve UBQLN3.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin inhibits mTOR, which can induce autophagy. UBQLN3 is suggested to be involved in autophagic degradation, and rapamycin could enhance this function of UBQLN3.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates PKC, which can phosphorylate various substrates. Phosphorylation by PKC might influence UBQLN3's activity in protein degradation pathways.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid modulates gene expression through nuclear receptors. It might enhance UBQLN3's function by influencing the transcription of genes involved in the pathways where UBQLN3 operates.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, causing ER stress. UBQLN3 could be activated in response to ER stress to facilitate the degradation of misfolded glycoproteins.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin disrupts ER calcium stores, causing ER stress. This might indirectly increase UBQLN3 activity as part of the cellular response to alleviate protein misfolding in the ER.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Bafilomycin A1 inhibits the vacuolar-type H+-ATPase, disrupting autophagy and lysosomal acidification. This could lead to increased UBQLN3-mediated autophagic protein degradation.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

AICAR activates AMPK, which can induce autophagy. Activation of autophagy could enhance the role of UBQLN3 in directing proteins for autophagic degradation.